NYSE American - Delayed Quote USD

Palatin Technologies, Inc. (PTN)

1.8200 +0.1000 (+5.81%)
At close: April 26 at 4:00 PM EDT
1.7600 -0.06 (-3.30%)
After hours: April 26 at 6:14 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Total Revenue
7,097.6980
4,853.6780
1,468.4570
-188.5970
117.9890
Cost of Revenue
330.9040
418.4700
217.5290
147.8400
--
Gross Profit
6,766.7940
4,435.2080
1,250.9280
-336.4370
117.9890
Operating Expense
37,645.3890
36,894.0910
37,839.3760
30,263.4720
23,724.7690
Operating Income
-30,878.5950
-32,458.8830
-36,588.4480
-30,599.9090
-23,606.7800
Net Non Operating Interest Income Expense
-17.4110
-20.0130
-29.6820
-23.4400
-20.1410
Other Income Expense
-4,147.9520
262.0100
419.8310
-2,973.1460
1,200.8980
Pretax Income
-35,043.9580
-32,216.8860
-36,198.2990
-33,596.4950
-22,426.0230
Tax Provision
--
-4,674.9990
--
--
--
Net Income Common Stockholders
-35,043.9580
-27,541.8870
-36,198.2990
-33,596.4950
-22,426.0230
Diluted NI Available to Com Stockholders
-35,043.9580
-27,541.8870
-36,198.2990
-33,596.4950
-22,426.0230
Basic EPS
-2.98
-2.53
-3.79
-3.55
-2.50
Diluted EPS
-2.98
-2.53
-3.79
-3.55
-2.50
Basic Average Shares
12,349.4650
10,890.1590
9,543.7620
9,466.0040
9,387.3910
Diluted Average Shares
12,349.4650
10,890.1590
9,543.7620
9,466.0040
9,387.3910
Total Operating Income as Reported
-23,055.1130
-32,458.8830
-36,588.4480
-33,384.1010
-23,606.7800
Total Expenses
37,976.2930
37,312.5610
38,056.9050
30,411.3120
23,724.7690
Net Income from Continuing & Discontinued Operation
-35,043.9580
-27,541.8870
-36,198.2990
-33,596.4950
-22,426.0230
Normalized Income
-30,477.1530
-27,765.8767
-36,618.1300
-30,623.3490
-23,626.9210
Interest Expense
17.4110
20.0130
29.6820
23.4400
20.1410
Net Interest Income
-17.4110
-20.0130
-29.6820
-23.4400
-20.1410
EBIT
-35,026.5470
-32,196.8730
-36,168.6170
-33,573.0550
-22,405.8820
EBITDA
-34,695.5590
-31,908.5420
-36,041.9490
-33,521.9340
-22,341.6790
Reconciled Cost of Revenue
330.9040
418.4700
217.5290
147.8400
--
Reconciled Depreciation
330.9880
288.3310
126.6680
51.1210
64.2030
Net Income from Continuing Operation Net Minority Interest
-35,043.9580
-27,541.8870
-36,198.2990
-33,596.4950
-22,426.0230
Total Unusual Items Excluding Goodwill
-4,566.8050
262.0100
419.8310
-2,973.1460
1,200.8980
Total Unusual Items
-4,566.8050
262.0100
419.8310
-2,973.1460
1,200.8980
Normalized EBITDA
-30,128.7540
-32,170.5520
-36,461.7800
-30,548.7880
-23,542.5770
Tax Rate for Calcs
--
0.0001
--
--
--
Tax Effect of Unusual Items
--
38.0203
--
--
--
6/30/2020 - 10/15/1997

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

EYEN Eyenovia, Inc.
0.6282
-11.68%
 
DOMH Dominari Holdings Inc.
2.7000
-0.37%
 
NRXP NRx Pharmaceuticals, Inc.
3.5400
+12.74%
 
VNDA Vanda Pharmaceuticals Inc.
4.6200
+3.12%
 
MBIO Mustang Bio, Inc.
0.3161
-11.58%
 
BRTX BioRestorative Therapies, Inc.
1.2500
+1.63%
 
LPCN Lipocine Inc.
4.7977
+6.14%
 
BLRX BioLineRx Ltd.
0.6116
+6.31%
 
FBIO Fortress Biotech, Inc.
1.7200
0.00%
 
ATHE Alterity Therapeutics Limited
2.5100
+9.61%